Bupropion is NOT recommended for treating intrusive thoughts and anxiety as a primary indication
Bupropion is FDA-approved only for major depressive disorder and seasonal affective disorder—not for anxiety disorders or obsessive-compulsive symptoms 1. While it may help anxiety symptoms that occur within the context of depression, the evidence shows it can actually worsen or trigger obsessive-compulsive symptoms and anxiety in some patients.
Key Evidence Against Use for Repetitive Thoughts
Case reports document that bupropion can actually cause obsessive-compulsive symptoms 2. Four patients with no prior OCD history developed progressive obsessive ideation and compulsions after starting bupropion, with complete symptom remission after discontinuation. This is the opposite of what you're seeking.
Evidence on Anxiety Effects: Mixed and Context-Dependent
In Depression WITH Comorbid Anxiety
- Bupropion shows comparable anxiolytic efficacy to SSRIs when treating depressed patients who also have anxiety symptoms 3
- A meta-analysis of 2,890 patients found no difference between bupropion and SSRIs in reducing Hamilton Anxiety Scale scores in MDD patients 3
- However, SSRIs showed modest superiority in patients with HIGH baseline anxiety 4
The Critical Caveat
- These studies measured anxiety as a secondary outcome in depression trials—not as a primary treatment target 4
- A 2023 naturalistic study found no difference in anxiety worsening between bupropion and SSRIs over 12 weeks, but this was in patients being treated for depression 5
- Bupropion's stimulating properties can provoke anxiety, particularly at higher doses 6
Clinical Algorithm
If the patient has:
- Primary anxiety or OCD symptoms WITHOUT depression → Do NOT use bupropion; choose SSRIs/SNRIs as first-line
- Major depression WITH mild-moderate anxiety → Bupropion is reasonable, comparable to SSRIs 3
- Major depression WITH severe anxiety or high baseline anxiety → Prefer SSRIs over bupropion 4
- Any history of obsessive-compulsive symptoms → Avoid bupropion due to risk of exacerbation 2
Important Safety Considerations
- Start at lower doses (150 mg daily) if anxiety is present to minimize anxiogenic effects 6
- Monitor closely for emergence or worsening of anxiety, agitation, or obsessive thoughts 1
- Bupropion is contraindicated in patients with seizure disorders or eating disorders 7
- The drug carries a black box warning for neuropsychiatric effects including anxiety, agitation, and suicidal ideation 7, 1
Bottom Line
For isolated repetitive thoughts and anxiety without depression, bupropion is inappropriate and potentially harmful. The drug may trigger or worsen obsessive-compulsive symptoms 2 and has anxiogenic potential 6. Its anxiolytic effects are limited to the context of treating major depressive disorder with comorbid anxiety, where it performs comparably to SSRIs in mild-moderate cases but is inferior to SSRIs in severe anxiety 4, 3.